Compugen Ltd. (CGEN)
NASDAQ: CGEN · Real-Time Price · USD
1.340
-0.020 (-1.47%)
At close: Sep 18, 2025, 4:00 PM EDT
1.360
+0.020 (1.49%)
After-hours: Sep 18, 2025, 4:16 PM EDT
Compugen Market Cap
Compugen has a market cap or net worth of $125.34 million as of September 18, 2025. Its market cap has decreased by -27.09% in one year.
Market Cap
125.34M
Enterprise Value
34.43M
1-Year Change
-27.09%
Ranking
Category
Stock Price
$1.34
Market Cap Chart
Since December 31, 2002, Compugen's market cap has increased from $46.50M to $125.34M, an increase of 169.54%. That is a compound annual growth rate of 4.46%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 18, 2025 | 125.30M | -8.54% |
Dec 31, 2024 | 137.00M | -21.58% |
Dec 29, 2023 | 174.70M | 181.77% |
Dec 30, 2022 | 62.00M | -82.82% |
Dec 31, 2021 | 360.80M | -64.38% |
Dec 31, 2020 | 1.01B | 183.96% |
Dec 31, 2019 | 356.70M | 220.49% |
Dec 31, 2018 | 111.30M | -12.91% |
Dec 29, 2017 | 127.80M | -50.45% |
Dec 30, 2016 | 257.90M | -19.68% |
Dec 31, 2015 | 321.10M | -5.97% |
Dec 31, 2014 | 341.50M | 4.27% |
Dec 31, 2013 | 327.50M | 91.74% |
Dec 31, 2012 | 170.80M | 1.73% |
Dec 30, 2011 | 167.90M | 3.83% |
Dec 31, 2010 | 161.70M | 16.92% |
Dec 31, 2009 | 138.30M | 1,033.61% |
Dec 31, 2008 | 12.20M | -72.95% |
Dec 31, 2007 | 45.10M | -37.45% |
Dec 29, 2006 | 72.10M | -38.95% |
Dec 30, 2005 | 118.10M | -14.61% |
Dec 31, 2004 | 138.30M | 4.38% |
Dec 31, 2003 | 132.50M | 184.95% |
Dec 31, 2002 | 46.50M | - |
Dec 31, 2002 | 46.50M | - |
View and export this data all the way back to 2002. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 682.40B |
Johnson & Johnson | 426.76B |
AbbVie | 390.07B |
UnitedHealth Group | 309.39B |
Novo Nordisk | 260.64B |
AstraZeneca | 241.43B |
Novartis AG | 237.64B |
Abbott Laboratories | 233.52B |